ITCI
Companies
NASDAQ
Intra-Cellular Therapies Inc.
Health Care
$131.87
+$48.35 (+57.89%)
Price Chart
Overview
About ITCI
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Market Cap
$7.2B
Volume
369.8M
Avg. Volume
307.0M
P/E Ratio
507.19232
Dividend Yield
0.00%
Employees
537.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Risk & Correlation Analysis
Market Correlation
1.18
Moderate Correlation
Volatility
High (0.54)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ITCI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$7.2B
Volume369.8M
P/E Ratio507.19
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 21, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025